SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019685
Filing Date
2022-05-12
Accepted
2022-05-12 08:32:13
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-10q_20220331.htm   iXBRL 10-Q 1734053
2 EX-31.1 apvo-ex311_8.htm EX-31.1 20683
3 EX-31.2 apvo-ex312_9.htm EX-31.2 20765
4 EX-32.1 apvo-ex321_10.htm EX-32.1 10173
5 EX-32.2 apvo-ex322_11.htm EX-32.2 10266
  Complete submission text file 0001564590-22-019685.txt   6233094

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA apvo-20220331.xsd EX-101.SCH 53032
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20220331_cal.xml EX-101.CAL 37844
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20220331_def.xml EX-101.DEF 163796
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20220331_lab.xml EX-101.LAB 388794
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20220331_pre.xml EX-101.PRE 286824
54 EXTRACTED XBRL INSTANCE DOCUMENT apvo-10q_20220331_htm.xml XML 903215
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 22915846
SIC: 2834 Pharmaceutical Preparations